AMGN FY 2012 Earnings Report — Amgen Inc. Revenue & Financial Results | Market Cap Arena

FY 2012 Earnings

Reported February 27, 2013

Quarter Comparison

Revenue

Operating Income

Gross Margin

Net Margin

EPS (Diluted)

Free Cash Flow

Metric	FY 2012	Prior Q	FY 2011	QoQ Change	YoY Change
Revenue	$17.3B	—	$15.6B	—	10.8%
Op. Income	$5.6B	—	$4.3B	—	29.3%
Gross Margin	83.1%	—	84.4%	—	-1.3pp
Net Margin	25.2%	—	23.6%	—	1.5pp
EPS (Diluted)	$5.52	—	$4.04	—	36.6%
Free Cash Flow	$5.2B	—	$4.6B	—	14.1%

Revenue Flow

Item	Amount
REVENUE	$17.3B
Cost of Revenue	$2.9B
GROSS PROFIT	$14.3B
R&D Expenses	$3.4B
Selling & Marketing	$0
General & Administrative	$0
SG&A Expenses	$4.8B
Other Expenses	$295M
Operating Expenses	$8.5B
Cost & Expenses	$11.7B
OPERATING INCOME	$5.6B
Interest Income	$485M
Interest Expense	$1.1B
Other Income/Expenses	-$568M
INCOME BEFORE TAX	$5.0B
Income Tax Expense	$664M
Net Income from Continuing Ops	$4.3B
Net Income from Discontinued Ops	$0
Other Adjustments	$0
NET INCOME	$4.3B
Net Income Deductions	$0
BOTTOM LINE NET INCOME	$4.3B
D&A	$1.1B
EBIT	$6.1B
EBITDA	$7.2B
EPS	$6
EPS Diluted	$6

Income Statement

Item	Amount
REVENUE	$17.3B
Cost of Revenue	$2.9B
GROSS PROFIT	$14.3B
R&D Expenses	$3.4B
Selling & Marketing	$0
General & Administrative	$0
SG&A Expenses	$4.8B
Other Expenses	$295M
Operating Expenses	$8.5B
Cost & Expenses	$11.7B
OPERATING INCOME	$5.6B
Interest Income	$485M
Interest Expense	$1.1B
Other Income/Expenses	-$568M
INCOME BEFORE TAX	$5.0B
Income Tax Expense	$664M
Net Income from Continuing Ops	$4.3B
Net Income from Discontinued Ops	$0
Other Adjustments	$0
NET INCOME	$4.3B
Net Income Deductions	$0
BOTTOM LINE NET INCOME	$4.3B
D&A	$1.1B
EBIT	$6.1B
EBITDA	$7.2B
EPS	$6
EPS Diluted	$6

Cash Flow Statement

Item	Amount
Net Income	$4.3B
Depreciation & Amortization	$1.1B
Stock-Based Compensation	$362M
Deferred Income Tax	$28M
Other Non-Cash Items	$104M
Change in Working Capital	-$45M
OPERATING CASH FLOW	$5.9B
Capital Expenditure	-$689M
Acquisitions (Net)	-$2.4B
Purchases of Investments	-$26.2B
Sales/Maturities of Investments	$19.4B
Other Investing Activities	-$36M
NET CASH FROM INVESTING	-$10.0B
Net Debt Issuance	$4.8B
Common Stock Repurchased	-$4.6B
Common Dividends Paid	-$1.1B
Other Financing Activities	$1.3B
NET CASH FROM FINANCING	$419M
FREE CASH FLOW	$5.2B
Net Change in Cash	-$3.7B

Balance Sheet

Item	Amount
Cash & Equivalents	$3.3B
Short-Term Investments	$20.8B
Net Receivables	$2.5B
Inventory	$2.7B
Other Current Assets	$1.9B
TOTAL CURRENT ASSETS	$31.2B
PP&E (Net)	$5.3B
Goodwill	$12.7B
Intangible Assets	$4.0B
Long-Term Investments	$0
Tax Assets	$0
Other Non-Current Assets	$1.1B
TOTAL NON-CURRENT ASSETS	$23.1B
TOTAL ASSETS	$54.3B
Account Payables	$905M
Short-Term Debt	$2.5B
Deferred Revenue	$0
Other Current Liabilities	$1.4B
TOTAL CURRENT LIABILITIES	$8.2B
Long-Term Debt	$24.0B
Deferred Revenue NC	$0
Deferred Tax Liabilities	$0
Other Non-Current Liabilities	$3.0B
TOTAL NON-CURRENT LIABILITIES	$27.0B
TOTAL LIABILITIES	$35.2B
Common Stock	$29.3B
Additional Paid-In Capital	$0
Retained Earnings	-$10.4B
Treasury Stock	$0
Accum. Other Comp. Income	$146M
Other Equity	$0
TOTAL STOCKHOLDERS' EQUITY	$19.1B
Minority Interest	$0
TOTAL EQUITY	$19.1B
TOTAL LIABILITIES & EQUITY	$54.3B
Total Debt	$26.5B
Net Debt	$23.3B